Global Botulinum Toxin Market

Botulinum Toxin Market Size, Share, Growth Analysis, By Type(Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use(Aesthetic, Therapeutics), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2220 | Region: Global | Published Date: July, 2001
Pages: 165 | Tables: 61 | Figures: 75

Botulinum Toxin Market Regional Insights

North America dominated the global botulinum toxin market in 2021, owing to the region's highly aware and economically stable population, as well as a significantly higher number of procedures conducted in the US and Canada. In 2021, more than 3.6 million cosmetic procedures involving neurotoxins (such as Botox) were performed. The increasing availability of numerous non-invasive cosmetic treatments and frequent new product approvals for a wide range of therapeutic indications are expected to fuel the expansion of botulinum toxin market over the forecast period.

Europe is second-largest botulinum toxin market because of high demand for botox operations in most of the European nations and increased research and development spending in Europe.

According to a study conducted in the United Kingdom, women who had assessed their self-esteem, life satisfaction, and attractiveness as low had little religious beliefs, and were exposed to a lot of media were more likely to get botox.

On the other hand, some of the developing countries in Asia Pacific and Latin America like India, China, Brazil, Thailand are experiencing a condierable growth in the demand for cosmetic surgeries that involves the use of botulinum toxin. The Asia Pacific botulinum toxin market growth is further supported by rising per capita disposable income, increased want to look beatuful and growing impact of social media are taking the market to next level. As a result, Asia Pacific botulinum toxin market is primed to see an increase in the demand for non-invasive aesthetic operations. According to the annual Global Aesthetic Survey conducted by the International Society of Aesthetic Plastic Surgery (ISAPS), medical tourism for cosmetic operations in Thailand is expanding, with more than 33.2% of cosmetic surgery patients coming from other countries.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Botulinum Toxin Market size was valued at USD 5.8 billion in 2019 and is poised to grow from USD 6.47 billion in 2023 to USD 17.23 billion by 2031, growing at a CAGR of 11.5% in the forecast period (2024-2031).

The key players in the botulinum toxin market are working on continuous innovation and product portfolio enhancement for better aesthetic and therapeutic outcomes for patients. For example, in February 2021, AbbVie, one of the prominent players in botulinum toxin market, got FDA clearance for Botox to treat detrusor overactivity associated with a neurological disease in select pediatric patients aged 5 and older. Furthermore, the growing relevance of aesthetic beauty, fueled by the expanding therapeutic applications of these toxins for critical and chronic diseases, is expected to drive the growth of botulinum toxin during the forecast period. 'Allergan', 'Ipsen', 'Merz Pharma', 'Medytox', 'Revance Therapeutics', 'US WorldMeds', 'Galderma', 'Hugel', 'Suneva Medical', 'Daewoong Pharmaceutical', 'Mylan', 'Evolus', 'Teijin Pharma', 'Anterios Inc.', 'Canbex Therapeutics', 'Lanzhou Institute of Biological Products', 'Eisai', 'SciClone Pharmaceuticals', 'InMed Pharmaceuticals', 'Syneron Medical'

Rising Demand for Minimally Invasive Cosmetic Procedures to Drive Botulinum Toxin Market

Women accounted for 92% of all cosmetic procedures performed around the globe while only 8 males undergo cosmetic procedures

North America dominated the botulinum toxin market in 2021, owing to the region's highly aware and economically stable population, as well as a significantly higher number of procedures conducted in the US and Canada. In 2021, more than 3.6 million cosmetic procedures involving neurotoxins (such as Botox) were performed. The increasing availability of numerous non-invasive cosmetic treatments and frequent new product approvals for a wide range of therapeutic indications are expected to fuel the expansion of botulinum toxin market over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Botulinum Toxin Market

Product ID: SQMIG35I2220

$5,300
BUY NOW GET FREE SAMPLE